InvestorsHub Logo
icon url

Toxic Avenger

01/30/11 7:42 PM

#55829 RE: roberto1 #55827

CNBC has no way to get current OS with the T/A gagged. They're using the last published numbers.

It's strange that under "Monthly Rotation", 1.7 million shares shows as 10.5% of total outstanding, yet in PK's ownership, 1.8 million shares shows as 4.2% of total outstanding.

I wouldn't put much faith in these numbers.
icon url

Drugdoctor

01/30/11 8:14 PM

#55830 RE: roberto1 #55827

40 million, 60 million, who cares? The float is small enough that this stock will rally hard when the financials hit. Let's say it's 60 million shares now, that means that some shares have either been converted for business reasons, or that some debt from previous convertibles has been converted to equity. Either way, it's a good use of the recapitalized DKAM share structure.

Of course 60 million shares would equal only $300,000 dollars market cap. Now suppose that DKAM reports 500,000 dollars in revenue for the quarter that ends tomorrow. That would be at a rate of 2 million in revenues for the next year, which would, have the price to sales ratio of the stock at .15... A price to sales ratio of 1 is considered low, but just to get back to 1 the stock would have to rally 667% or back to .033.

Bottom line, for an emerging small cap, REVENUE IS KING, and DKAM's revenue is growing at a huge clip, therefore by any measure, DKAM is selling at a huge discount to a normal Price to Sales ratio...

GLTA